A sensational investigative report by by Harriet Ryan, Lisa Girion and Scott Glover in the Los Angeles Times (May 5, 2016) exposes the irresponsible, corrupt practices of Purdue Pharmaceuticals, the company that manufactures and aggressively markets OxyContin at a dosing schedule that some doctors have described as “an addiction producing machine.”…
The Chronicle of Higher Education looks at the increasingly dark side of conflicts of interest in academia.
Pharmaceutical companies willingly settle court cases for hundreds of millions of dollars–even billions of dollars–to keep the truth about their drugs under seal.
The deceptive marketing of antipsychotic drugs has prompted new advocacy group to launch "The Just Say "Know" to Prescription Drugs Campaign." Its goal is to get one million people to stop and reevaluate the medications they are taking.
A federal Judge of the Eastern District (Brooklyn) issued a ruling upholding a seal on documents that contain evidence linking Zyprexa, Eli Lilly's antipsychotic drug to diabetes
Despite Lilly's efforts to suppress the documents, they are available on internet websites.
Judge Jack Weinstein rejected Lilly's effort to seek a court injunction against internet posting
of the documents.
These illegal practices are the secret behind this toxic drug–Zyprexa– becoming a blockbuster seller.
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
The question is: will Eli Lilly succeed, once again, to divert public attention from the revelations contained in its internal documents about the company's illegal marketing practices and its failure to warn about lethal risks posed by its product?
"The voluntary consent of the human subject is absolutely essential," reads the Nuremberg Code of 1947, which was drafted in direct response to the sheer barbarity of Nazi-era medical experiments on Jews and other captive groups.
